321 related articles for article (PubMed ID: 30041030)
1. Expression analysis of human solute carrier (SLC) family transporters in nasal mucosa and RPMI 2650 cells.
Dolberg AM; Reichl S
Eur J Pharm Sci; 2018 Oct; 123():277-294. PubMed ID: 30041030
[TBL] [Abstract][Full Text] [Related]
2. Activity of Multidrug Resistance-Associated Proteins 1-5 (MRP1-5) in the RPMI 2650 Cell Line and Explants of Human Nasal Turbinate.
Dolberg AM; Reichl S
Mol Pharm; 2017 May; 14(5):1577-1590. PubMed ID: 28291371
[TBL] [Abstract][Full Text] [Related]
3. Expression of P-glycoprotein in excised human nasal mucosa and optimized models of RPMI 2650 cells.
Dolberg AM; Reichl S
Int J Pharm; 2016 Jul; 508(1-2):22-33. PubMed ID: 27155589
[TBL] [Abstract][Full Text] [Related]
4. Optimization of human nasal epithelium primary culture conditions for optimal proton oligopeptide and organic cation transporters expression in vitro.
Shao D; Massoud E; Clarke D; Cowley E; Renton K; Agu RU
Int J Pharm; 2013 Jan; 441(1-2):334-42. PubMed ID: 23178597
[TBL] [Abstract][Full Text] [Related]
5. SLC Family Transporters.
Liu X
Adv Exp Med Biol; 2019; 1141():101-202. PubMed ID: 31571165
[TBL] [Abstract][Full Text] [Related]
6. Organic cation transporters in human nasal primary culture: expression and functional activity.
Shao D; Massoud E; Anand U; Parikh A; Cowley E; Clarke D; Agu RU
Ther Deliv; 2013 Apr; 4(4):439-51. PubMed ID: 23557285
[TBL] [Abstract][Full Text] [Related]
7. Microarray Determination of the Expression of Drug Transporters in Humans and Animal Species Used for the Investigation of Nasal Absorption.
Al-Ghabeish M; Scheetz T; Assem M; Donovan MD
Mol Pharm; 2015 Aug; 12(8):2742-54. PubMed ID: 26106909
[TBL] [Abstract][Full Text] [Related]
8. Suitability of RPMI 2650 cell models for nasal drug permeability prediction.
Sibinovska N; Žakelj S; Kristan K
Eur J Pharm Biopharm; 2019 Dec; 145():85-95. PubMed ID: 31639418
[TBL] [Abstract][Full Text] [Related]
9. Establishment of a novel microscale thermophoresis ligand-binding assay for characterization of SLC solute carriers using oligopeptide transporter PepT1 (SLC15 family) as a model system.
Clémençon B; Lüscher BP; Hediger MA
J Pharmacol Toxicol Methods; 2018; 92():67-76. PubMed ID: 29580877
[TBL] [Abstract][Full Text] [Related]
10. Application of RPMI 2650 as a cell model to evaluate solid formulations for intranasal delivery of drugs.
Gonçalves VSS; Matias AA; Poejo J; Serra AT; Duarte CMM
Int J Pharm; 2016 Dec; 515(1-2):1-10. PubMed ID: 27702697
[TBL] [Abstract][Full Text] [Related]
11. RT-PCR analysis of ABC, SLC and SLCO drug transporters in human lung epithelial cell models.
Endter S; Francombe D; Ehrhardt C; Gumbleton M
J Pharm Pharmacol; 2009 May; 61(5):583-91. PubMed ID: 19405996
[TBL] [Abstract][Full Text] [Related]
12. Is RPMI 2650 a Suitable In Vitro Nasal Model for Drug Transport Studies?
Mercier C; Perek N; Delavenne X
Eur J Drug Metab Pharmacokinet; 2018 Feb; 43(1):13-24. PubMed ID: 28688000
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibition of human solute carrier transporters by multikinase inhibitors.
Johnston RA; Rawling T; Chan T; Zhou F; Murray M
Drug Metab Dispos; 2014 Nov; 42(11):1851-7. PubMed ID: 25165131
[TBL] [Abstract][Full Text] [Related]
14. Drug transporter expression and localization in rat nasal respiratory and olfactory mucosa and olfactory bulb.
Genter MB; Krishan M; Augustine LM; Cherrington NJ
Drug Metab Dispos; 2010 Oct; 38(10):1644-7. PubMed ID: 20660103
[TBL] [Abstract][Full Text] [Related]
15. Regional levels of drug transporters along the human intestinal tract: co-expression of ABC and SLC transporters and comparison with Caco-2 cells.
Englund G; Rorsman F; Rönnblom A; Karlbom U; Lazorova L; Gråsjö J; Kindmark A; Artursson P
Eur J Pharm Sci; 2006 Nov; 29(3-4):269-77. PubMed ID: 16822659
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Substrate Characterization of 22 Antituberculosis Drugs for Multiple Solute Carrier (SLC) Uptake Transporters
Parvez MM; Kaisar N; Shin HJ; Lee YJ; Shin JG
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 30012768
[TBL] [Abstract][Full Text] [Related]
17. The impact of solute carrier (SLC) drug uptake transporter loss in human and rat cryopreserved hepatocytes on clearance predictions.
Lundquist P; Lööf J; Sohlenius-Sternbeck AK; Floby E; Johansson J; Bylund J; Hoogstraate J; Afzelius L; Andersson TB
Drug Metab Dispos; 2014 Mar; 42(3):469-80. PubMed ID: 24396146
[TBL] [Abstract][Full Text] [Related]
18. Drug transporters in the nasal epithelium: an overview of strategies in targeted drug delivery.
Anand U; Parikh A; Ugwu MC; Agu RU
Future Med Chem; 2014; 6(12):1381-97. PubMed ID: 25329195
[TBL] [Abstract][Full Text] [Related]
19. Antitubercular Agent Delamanid and Metabolites as Substrates and Inhibitors of ABC and Solute Carrier Transporters.
Sasabe H; Shimokawa Y; Shibata M; Hashizume K; Hamasako Y; Ohzone Y; Kashiyama E; Umehara K
Antimicrob Agents Chemother; 2016 Jun; 60(6):3497-508. PubMed ID: 27021329
[TBL] [Abstract][Full Text] [Related]
20. Interactions of organophosphorus pesticides with solute carrier (SLC) drug transporters.
Chedik L; Bruyere A; Fardel O
Xenobiotica; 2019 Mar; 49(3):363-374. PubMed ID: 29448871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
